Fundz

Micron Biomedical Secures Series A Financing To Commercialize Map Technology For Self-Administration Of Drugs And Vaccines Without Needles

PRIVATENov 28, 2022

Round Type

Series A

AtlantaBiotechnologyHealth Care

Investors

Gra Venture FundGlobal Health Investment Corporation

Description

Micron Biomedical, Inc. is a clinical stage life sciences company advancing its Micro Array Patch (MAP) technology for self-administration and simple, less-skilled caregiver administration of drugs and vaccines without needles. The $14 million Series A financing will support the company's development of commercial manufacturing, currently underway and establishes a strong partnership between Micron and LTS Lohmann. Micron's development pipeline includes vaccine and drug products partnered with pharma companies, foundations, and government agencies

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as Micron Biomedical that raised within 45 days of this round, from Fundz verified event records.

  • Wheeler Bio raised an undisclosed amount (Funding Round) on January 12, 2023.
  • LinusBio raised $16M (Funding Round) on January 12, 2023.
  • Vero Biotech Inc. raised $30M (Funding Round) on January 11, 2023.
  • MPC Therapeutics raised an undisclosed amount (Seed) on January 11, 2023.
  • ReCode Therapeutics raised an undisclosed amount (Corporate Round) on January 10, 2023.
  • Medix Infusion raised $35M (Series B) on January 10, 2023.

Who to call at Micron Biomedical, and when

A new round usually means Micron Biomedical is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Micron Biomedical raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Micron Biomedical, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Micron Biomedical. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Micron Biomedical

Location

Atlanta, Georgia, United States

About

Micron Biomedical, Inc. is a clinical-stage biopharmaceutical company on a rapid path to bring to market drugs and vaccines that are formulated into a proprietary patch technology that simplifies and improves the way actives are delivered, stored, and distributed. This technology is designed to increase patient access to drugs and vaccines that would otherwise require expert injection and to improve safety and efficacy by skin targeting.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Micron Biomedical raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts5 people are listed at Micron Biomedical. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Micron Biomedical's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

Micron Biomedical raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.